# New Animal Drugs; Trilostane
> **Food and Drug Administration** · Final rule. · Published 2009-05-11 · Effective 2009-05-11 · 74 FR 21767
## Document
- **Document number:** E9-10927
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 74 FR 21767
- **CFR reference:** 21 CFR 510
- **Publication date:** 2009-05-11
- **Effective date:** 2009-05-11
- **HHS docket:** Docket No. FDA-2009-N-0665
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the original approval of a new animal drug application (NADA) filed by Dechra, Ltd. The NADA provides for the veterinary prescription use of trilostane capsules in dogs for treatment of pituitary-dependent hyperadrenocorticism and for treatment of hyperadrenocorticism due to adrenocortical tumor.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2009/05/11/E9-10927/new-animal-drugs-trilostane)
---
*AI Analytics · CC0 1.0*